Patent · US Active

Variant ICOS ligand immunomodulatory proteins and related compositions and methods

US11613566B2 · kind B2 · utility

1Cited by

74References

4Claims

0Family size

Assignee

Alpine Immune Sciences, Inc. · US

Inventors

Lawrence Evans · Dorris, US
Michael Kornacker · Seattle, US
Ryan Swanson · Seattle, US

Key dates

Filing date	Dec 22, 2021
Grant date	Mar 28, 2023
Priority date	—
Expiry date	Dec 22, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/43
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are immunomodulatory proteins comprising ICOSL variants and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.